636
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Patents and R&D expenditure effects on equity returns in pharmaceutical industry

&

References

  • Coombs, J. E., and P. E. Bierly. 2006. “Measuring Technological Capability and Performance.” R and D Management 36: 421–438. doi:10.1111/radm.2006.36.issue-4.
  • Cutler, D. M. 2007. “The Demise of the Blockbuster?” New England Journal of Medicine 356: 1292–1293. doi:10.1056/NEJMp078020
  • Fama, E., and K. French. 1993. “Common Risk Factors in the Returns on Stocks and Bonds.” Journal of Financial Economics 33: 3–56. doi:10.1.1.139.5892.
  • Findlay, S. M. 2006. “Market Analysis: Beating the Blockbuster Blues.” Pharmaceutical Technology Europe 18: 20–22.
  • Grabowski, H. 2002. “Patents, Innovation and Access to New Pharmaceuticals.” Journal of International Economic Law 5: 849–860. doi:10.1093/jiel/5.4.849.
  • Hahn, J., and H. Lee. 2009. “Financial Constraints, Debt Capacity, and the Cross-section of Stock Returns.” Journal of Finance 64: 891–921. doi:10.1111/j.1540-6261.2009.01452.x.
  • Herper, M. 2011a. “Pfizer’s Radical Surgery.” Forbes 187: 86–91.
  • Herper, M. 2011b. “The Blockbuster Drug Comes to an End.” Forbes 187: 26.
  • Houlton, S. 2009. “The End of Blockbusters?” Chemistry & Industry 6: 14–15.
  • Jensen, P., R. Thomson, and J. Yong. 2011. “Estimating the Patent Premium: Evidence from the Australian Inventor Survey.” Strategic Management Journal 32: 1128–1138. doi:10.1002/smj.v32.10.
  • Kim, T. Y., K. J. Oh, C. Kim, and J. D. Do. 2004. “Artificial Neural Networks for Non-Stationary Time Series.” Neurocomputing 61: 439–447. doi:10.1016/j.neucom.2004.04.002.
  • Lazonick, W., and O. Tulum. 2011. “US Biopharmaceutical Finance and the Sustainability of the Biotech Business Model.” Research Policy 40: 1170–1187. doi:10.1016/j.respol.2011.05.021.
  • Munos, B. H., and W. W. Chin. 2009. “A Call for Sharing: Adapting Pharmaceutical Research to New Realities.” Science Translational Medicine 1 (9): 9cm8. doi:10.1126/scitranslmed.3000155.
  • Nordlie, E., M.-O. Gewaltig, H. E. Plesser, and K. J. Friston. 2009. “Towards Reproducible Descriptions of Neuronal Network Models.” PLoS Computational Biology 5 (8): e1000456. doi:10.1371/journal.pcbi.1000456.
  • Phillips, P., and D. Sul. 2007. “Bias in Dynamic Panel Estimation with Fixed Effects, Incidental Trends and Cross Section Dependence.” Journal of Econometrics 137: 162–188. doi:10.1016/j.jeconom.2006.03.009.
  • Rees, L. L., and S. Sivaramakrishnan. 2007. “The Effect of Meeting or Beating Revenue Forecasts on the Association between Quarterly Returns and Earnings Forecast Errors.” Contemporary Accounting Research 24: 259–290. doi:10.2139/ssrn.655421.
  • Service, R. F. 2004. “Surviving the Blockbuster Syndrome.” Science 303 (5665): 1796–1799. doi:10.1126/science.303.5665.1796.
  • Sharabati, A. A., and A. N. Ibrahim. 2013. “Intellectual Property Rights and Pharmaceutical Manufacturing Organizations’ Business Performance.” Journal of Business Studies Quarterly 4: 112–128. Barton (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.